Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis

Immunological Investigations

Volumn 43, Issue 7, 2014, Pages 705-716

  Zheng, Mingke ^a,b   Xing, Chen ^a   Xiao, He ^a   Ma, Ning ^a,c   Wang, Xiaoqian ^a   Han, Gencheng ^a   Chen, Guojiang ^a   Hou, Chunmei ^a   Shen, Beifen ^a   Li, Yan ^a   Wang, Renxi ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

CD5; CD72; Immune homeostasis; Regulatory B cells; Regulatory T cells

Indexed keywords

CD5 ANTIGEN; CD72 ANTIGEN; INTERLEUKIN 10; B LYMPHOCYTE ANTIGEN; CD5 PROTEIN, MOUSE; CD72 ANTIGEN, MOUSE; IL10 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL EXPANSION; CELL INTERACTION; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; ANIMAL; C57BL MOUSE; COCULTURE; CYTOLOGY; IMMUNOLOGY; SPLEEN;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD5; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES, REGULATORY; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HOMEOSTASIS; INTERLEUKIN-10; MALE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 84907034001     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2014.917096     Document Type: Article

References (37)

1. Albert MH, Liu Y, Anasetti C, Yu XZ. (2005). Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory Tcells in transplantation. Eur J Immunol, 35, 2598-607.
2. Asano M, Toda M, Sakaguchi N, Sakaguchi S. (1996). Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med, 184, 387-96.
3. Brummel R, Lenert P. (2005). Activation of marginal zone B cells from lupus mice with type A (D) CpG-oligodeoxynucleotides. J Immunol, 174, 2429-34.
4. Carter NA, Vasconcellos R, Rosser EC, et al. (2011). Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol, 186, 5569-79.
5. Chai JG, Xue SA, Coe D. (2005). Regulatory T cells, derived from naive CD4+CD25-T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation, 79, 1310-6.
6. Choi YS, Jeong JA, Lim DS. (2012). Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T Cell-based immunosuppressive effect. Immunol Invest, 41, 214-29.
7. Ding Q, Yeung M, Camirand G, et al. (2011). Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest, 121, 3645-56.
8. Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. (2007). Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol, 178, 7868-78.
9. Fillatreau S, Gray D, Anderton SM. (2008). Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol, 8, 391-7.
10. Fontenot JD, Gavin MA, Rudensky AY. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol, 4, 330-6.
11. Garaud S, Le Dantec C, de Mendoza AR, et al. (2009). IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann NY Acad Sci, 1173, 280-5.
12. Garaud S, Morva A, Lemoine S, et al. (2011). CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT2 and NFAT2 activation. J Immunol, 186, 4835-44.
13. Gray M, Miles K, Salter D, et al. (2007). Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA, 104, 14080-5.
14. Haas KM, Watanabe R, Matsushita T, et al. (2010). Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol, 184, 4789-800.
15. Hori S, Nomura T, Sakaguchi S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-61.
16. Ibrahim L, Salah M, Rahman AAE, et al. (2013). Crucial Role of CD4+CD25+ FOXP3+ T regulatory cell, interferon-g and interleukin-16 in malignant and tuberculous pleural effusions. Immunol Invest, 42, 122-36.
17. Jaeckel E, von-Boehmer H, Manns MP. (2005). Antigen-specific Foxp3-transduced Tcells can control established type 1 diabetes. Diabetes, 54, 306-10.
18. Kalampokis I, Yoshizaki A, Tedder TF. (2013). IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther, 15(S1), 1-12.
19. Khattri R, Cox T, Yasayko SA, Ramsdell F. (2003). An essential role for Scurfin in CD4+CD25+T regulatory cells. Nat Immunol, 4, 337-42.
20. Lenert P, Brummel R, Field EH, Ashman RF. (2005). TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol, 25, 29-40.
21. Loser K, Hansen W, Apelt J, et al. (2005). In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther, 12, 1294-304.
22. Maggi E, Cosmi L, Liotta F, et al. (2005). Thymic regulatory T cells. Autoimmun Rev, 4, 579-86.
23. Maseda D, Smith SH, DiLillo DJ, et al. (2012). Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol, 188, 1036-48.
24. Matsushita T, Yanaba K, Bouaziz Z-D, et al. (2008). Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest, 118, 3420-30.
25. Mauri C, Bosma A. (2012). Immune regulatory function of B cells. Annu Rev Immunol, 30, 221-41.
26. Mauri C, Ehrenstein MR. (2008). The 'short' history of regulatory B cells. Trends Immunol, 29, 34-40.
27. Mizoguchi A, Mizoguchi E, Takedatsu H, et al. (2002). Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity, 16, 219-30.
28. Pistoia V. (1997). Production of cytokines by human B cells in health and disease. Immunol Today, 18, 343-50.
29. Sakaguchi S, Sakaguchi N, Asano M, et al. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155, 1151-64.
30. Schioppa T, Moore R, Thompson RG, et al. (2011). B regulatory cells and the tumorpromoting actions of TNF-alpha during squamous carcinogenesis. Proc Natl Acad Sci USA, 108, 10662-7.
31. Shevach E. (2000). Regulatory T cells in autoimmunity. Annu Rev Immunol, 18, 423-49.
32. Tadmor T, Zhang Y, Cho HM, et al. (2011). The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol Immunother, 60, 609-19.
33. Velaga S, Ukena SN, Hpting M, et al. (2013). Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation. Immunol Invest, 42, 18-25.
34. Xing Q, Su H, Cui J, Wang B. (2012). Role of Treg cells and TGF-beta1 in patients with Systemic Lupus Erythematosus: A possible relation with Lupus Nephritis. Immunol Invest, 41, 15-27.
35. Yanaba K, Bouaziz JD, Haas KM, et al. (2008). A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T celldependent inflammatory responses. Immunity, 28, 639-50.
36. Yanaba K, Bouaziz J-D, Matsushita T, et al. (2009). The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol, 182, 7459-72.
37. Zhang Y, Jiang L, Zhang M, Lv K. (2014). Galectin-9 induced myeloid suppressor cells expand regulatory T cells in an IL-10-dependent manner in CVB3-induced acute myocarditis. Int J Mol Sci, 15, 3356-72.